Literature DB >> 15148152

Copper perturbation in 2 monozygotic twins discordant for degree of cognitive impairment.

Rosanna Squitti1, Emanuele Cassetta, Gloria Dal Forno, Domenico Lupoi, Giulia Lippolis, Flavia Pauri, Fabrizio Vernieri, Antonella Cappa, Paolo M Rossini.   

Abstract

BACKGROUND: Recent evidence indicates that peripheral tissue markers can provide information regarding changes affecting cellular metabolism in Alzheimer disease (AD). We previously reported that serum copper levels can discriminate subjects with AD from normal control subjects (with 60% sensitivity and 95% specificity) and from patients with vascular dementia (with 63% sensitivity and 85% specificity).
OBJECTIVE: To study the correlation between AD and serum levels of transition metals and markers of peripheral oxidative stress.
DESIGN: Case study.
SETTING: General hospital inpatient wards and outpatient clinics. Patients A pair of elderly monozygotic female twins discordant for AD. MAIN OUTCOME MEASURES: Biochemical analyses of peripheral-blood transition metals and indicators of oxidative stress and neurologic and neuropsychological assessments of clinical status for presence of cognitive impairment and AD.
RESULTS: Serum copper and total peroxide levels were both 44% higher in the twin with greater cognitive impairment and a diagnosis of AD.
CONCLUSIONS: The cases reported support the hypothesis of a major involvement of copper and oxidative abnormalities in AD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15148152     DOI: 10.1001/archneur.61.5.738

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  9 in total

1.  HSPA5 forms specific complexes with copper.

Authors:  Yongchang Qian; Bingchao Meng; Xuchu Zhang; Ying Zheng; Robert Taylor; Evelyn Tiffany-Castiglioni
Journal:  Neurochem Res       Date:  2012-11-17       Impact factor: 3.996

2.  The amyloid precursor protein copper binding domain histidine residues 149 and 151 mediate APP stability and metabolism.

Authors:  Loredana Spoerri; Laura J Vella; Chi L L Pham; Kevin J Barnham; Roberto Cappai
Journal:  J Biol Chem       Date:  2012-06-08       Impact factor: 5.157

Review 3.  Metal ion physiopathology in neurodegenerative disorders.

Authors:  Silvia Bolognin; Luigi Messori; Paolo Zatta
Journal:  Neuromolecular Med       Date:  2009-11-28       Impact factor: 3.843

4.  Effect of copper intake on CSF parameters in patients with mild Alzheimer's disease: a pilot phase 2 clinical trial.

Authors:  Holger Kessler; Frank-Gerald Pajonk; Daniela Bach; Thomas Schneider-Axmann; Peter Falkai; Wolfgang Herrmann; Gerd Multhaup; Jens Wiltfang; Stephanie Schäfer; Oliver Wirths; Thomas A Bayer
Journal:  J Neural Transm (Vienna)       Date:  2008-10-30       Impact factor: 3.575

5.  Paradigm shift in treatment of Alzheimer's disease: zinc therapy now a conscientious choice for care of individual patients.

Authors:  Tjaard U Hoogenraad
Journal:  Int J Alzheimers Dis       Date:  2011-09-22

6.  Intake of copper has no effect on cognition in patients with mild Alzheimer's disease: a pilot phase 2 clinical trial.

Authors:  Holger Kessler; Thomas A Bayer; Daniela Bach; Thomas Schneider-Axmann; Tillmann Supprian; Wolfgang Herrmann; Manfred Haber; Gerd Multhaup; Peter Falkai; Frank-Gerald Pajonk
Journal:  J Neural Transm (Vienna)       Date:  2008-06-28       Impact factor: 3.575

7.  Ceruloplasmin (2-D PAGE) Pattern and Copper Content in Serum and Brain of Alzheimer Disease Patients.

Authors:  Rosanna Squitti; Carlo C Quattrocchi; Gloria Dal Forno; Piero Antuono; David R Wekstein; Concetta R Capo; Carlo Salustri; Paolo M Rossini
Journal:  Biomark Insights       Date:  2007-02-07

8.  Decreased copper in Alzheimer's disease brain is predominantly in the soluble extractable fraction.

Authors:  Alan Rembach; Dominic J Hare; Monica Lind; Christopher J Fowler; Robert A Cherny; Catriona McLean; Ashley I Bush; Colin L Masters; Blaine R Roberts
Journal:  Int J Alzheimers Dis       Date:  2013-10-21

9.  Reciprocal modulation of Aβ42 aggregation by copper and homocysteine.

Authors:  Salla Keskitalo; Melinda Farkas; Michael Hanenberg; Anita Szodorai; Luka Kulic; Alexander Semmler; Michael Weller; Roger M Nitsch; Michael Linnebank
Journal:  Front Aging Neurosci       Date:  2014-09-08       Impact factor: 5.750

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.